Your browser doesn't support javascript.
loading
Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study.
D'Costa, Matthew R; Haley, William E; Mara, Kristin C; Enders, Felicity T; Vrtiska, Terri J; Pais, Vernon M; Jacobsen, Steven J; McCollough, Cynthia H; Lieske, John C; Rule, Andrew D.
Afiliação
  • D'Costa MR; Divisions of Nephrology and Hypertension, and.
  • Haley WE; Division of Nephrology, Mayo Clinic, Jacksonville, Florida.
  • Mara KC; Biomedical Statistics and Informatics, and.
  • Enders FT; Biomedical Statistics and Informatics, and.
  • Vrtiska TJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
  • Pais VM; Department of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and.
  • Jacobsen SJ; Department of Research, Kaiser Permanente, Pasadena, California.
  • McCollough CH; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
  • Lieske JC; Divisions of Nephrology and Hypertension, and.
  • Rule AD; Divisions of Nephrology and Hypertension, and Rule.Andrew@mayo.edu.
J Am Soc Nephrol ; 30(7): 1251-1260, 2019 07.
Article em En | MEDLINE | ID: mdl-31175141
ABSTRACT

BACKGROUND:

Meaningful interpretation of changes in radiographic kidney stone burden requires understanding how radiographic recurrence relates to symptomatic recurrence and how established risk factors predict these different manifestations of recurrence.

METHODS:

We recruited first-time symptomatic stone formers from the general community in Minnesota and Florida. Baseline and 5-year follow-up study visits included computed tomography scans, surveys, and medical record review. We noted symptomatic recurrence detected by clinical care (through chart review) or self-report, and radiographic recurrence of any new stone, stone growth, or stone passage (comparing baseline and follow-up scans). To assess the prediction of different manifestations of recurrence, we used the Recurrence of Kidney Stone (ROKS) score, which sums multiple baseline risk factors.

RESULTS:

Among 175 stone formers, 19% had symptomatic recurrence detected by clinical care and 25% detected by self-report; radiographic recurrence manifested as a new stone in 35%, stone growth in 24%, and stone passage in 27%. Among those with a baseline asymptomatic stone (54%), at 5 years, 51% had radiographic evidence of stone passage (accompanied by symptoms in only 52%). Imaging evidence of a new stone or stone passage more strongly associated with symptomatic recurrence detected by clinical care than by self-report. The ROKS score weakly predicted one manifestation-symptomatic recurrence resulting in clinical care (c-statistic, 0.63; 95% confidence interval, 0.52 to 0.73)-but strongly predicted any manifestation of symptomatic or radiographic recurrence (5-year rate, 67%; c-statistic, 0.79; 95% confidence interval, 0.72 to 0.86).

CONCLUSIONS:

Recurrence after the first stone episode is both more common and more predictable when all manifestations of recurrence (symptomatic and radiographic) are considered.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cálculos Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cálculos Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article